EIF6 and colorectal carcinoma: Dysregulation of eIF6 function and expression has been previously discovered in various types of malignancies, including breast cancer, colorectal carcinoma (CRC), malignant pleural mesothelioma (MPM) and ovarian adenocarcinoma [16–18].